Skip to main content
Fig. 2 | BMC Molecular and Cell Biology

Fig. 2

From: lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p

Fig. 2

Prognosis of TNBC patients according to the expression of ACTA2-AS1 (A) and miR-532-5p (B). Both ACTA2-AS1 downregulation (log rank P = 0.034) and miR-532-5p upregulation (log rank P = 0.018) are associated with the poor prognosis of TNBC patients. The online dataset verified the significant prognostic value of ACTA2-AS1 (C) and miR-532-5p (D) in breast cancer

Back to article page